Free Delivery Over $100
|
|
|||
|
||||
OverviewThis first systematic summary of the impact of fragment-based approaches on the drug development process provides essential information that was previously unavailable. Adopting a practice-oriented approach, this represents a book by professionals for professionals, tailor-made for drug developers in the pharma and biotech sector who need to keep up-to-date on the latest technologies and strategies in pharmaceutical ligand design. The book is clearly divided into three sections on ligand design, spectroscopic techniques, and screening and drug discovery, backed by numerous case studies. Full Product DetailsAuthor: W Jahnke , Wolfgang Jahnke (Novartis Pharma, Basel, Switzerland) , Daniel A Erlanson (Sunesis Pharmaceuticals, Inc., San Francisco, USA)Publisher: Wiley-VCH Verlag GmbH Imprint: Wiley-VCH Verlag GmbH ISBN: 9781280722813ISBN 10: 1280722819 Pages: 392 Publication Date: 01 January 2006 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
